Work

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project

Year: 2015
Type: article
Institutions: Centre Oscar Lambret, Onco Lille, Lyon 1 Université, Centre Léon Bérard, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, Universitair Ziekenhuis Leuven, Radboud University Medical Center, Queen Mary University of London, Barts Cancer Institute, The Netherlands Cancer Institute, Centre Hospitalier Universitaire de Besançon, Methodology and Quality of Life Unit in Oncology, Institut Gustave Roussy, Ospedale San Donato, Cleveland Clinic, University of Sheffield, Dana-Farber Cancer Institute, University of Southampton, Cambridge University Health Partners, Centre Hospitalier Universitaire de Nîmes, University College Dublin, Mater Misericordiae University Hospital, Université Lille Nord de France, Friedrich-Alexander-Universität Erlangen-Nürnberg, Institut Paoli-Calmettes, MRC Clinical Trials Unit at UCL, University College London, Centre Hospitalier Universitaire de Toulouse, Palacký University Olomouc, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, Mount Vernon Cancer Centre, Policlinico San Matteo Fondazione, Hôpital Saint-Louis, University of Southern California, USC Norris Comprehensive Cancer Center, Hôpital Saint-André, Institut de Cancérologie de l'Ouest, Comprehensive Cancer Center Vienna, Medical University of Vienna, Cliniques Universitaires Saint-Luc, Institut Regional du Cancer de Montpellier, Centre Eugène Marquis, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliero Universitaria Maggiore della Carita
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W1680378644
FWCI: 3.167
Cites: 18
Cited by: 30
Related to: 10